Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | CA4 | P22748 | 4/20 | 0.45 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL29483921 | 1.00 | LMNA (0.50) | LMNATSHRCA4FAHD1CA1 | |
| Cadaverine Tartrate SCHEMBL30052254 | 1.00 | LMNA (0.50) | LMNATSHRCA4FAHD1CA1 | |
| Cadaverine Tartrate SCHEMBL24913 | 1.00 | LMNA (0.50) | LMNATSHRCA4FAHD1CA1 | |
| Cadaverine Tartrate SCHEMBL8811290 | 0.96 | LMNA (0.48) | LMNATSHRCA4FAHD1CA1 | |
| Cadaverine Tartrate SCHEMBL3858 | 0.96 | CA4 (0.50) | LMNATSHRCA4FAHD1CA1 | |
| Cadaverine Tartrate SCHEMBL7516215 | 0.96 | LMNA (0.48) | LMNATSHRCA4FAHD1CA1 | |
| Cadaverine Tartrate SCHEMBL10932711 | 0.96 | LMNA (0.48) | LMNATSHRCA4FAHD1CA1 | |
| Cadaverine Tartrate SCHEMBL15206510 | 0.96 | LMNA (0.48) | LMNATSHRCA4FAHD1CA1 | |
| Cadaverine Tartrate SCHEMBL10902649 | 0.96 | LMNA (0.48) | LMNATSHRCA4FAHD1CA1 | |
| Cadaverine Tartrate SCHEMBL7512911 | 0.96 | LMNA (0.48) | LMNATSHRCA4FAHD1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3636253-B1 | SEAMLESS CAPSULE SHELL COMPOSITION AND SEAMLESS CAPSULE | FUJI CAPSULE CO LTD (JP) | 2023-09-13 | — | — | EP | disclosed |
| US-11364206-B2 | Seamless capsule shell composition and seamless capsule | FUJI CAPSULE CO., LTD. (JP) | 2022-06-21 | — | — | US | disclosed |
| US-20200155464-A1 | Seamless Capsule Shell Composition and Seamless Capsule | NISSHIN KASEI CO., LTD. (JP) | 2020-05-21 | — | — | US | disclosed |
| US-20200152986-A1 | ALL-SOLID SECONDARY BATTERY AND METHOD OF MANUFACTURING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2020-05-14 | — | — | US | disclosed |
| EP-3636253-A1 | SEAMLESS CAPSULE COATING COMPOSITION AND SEAMLESS CAPSULE | Fuji Capsule Co., Ltd. (JP) | 2020-04-15 | — | — | EP | disclosed |
| US-8900628-B2 | Hard capsule and method for producing same | NISSHIN KASEI CO., LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| EP-2540286-A1 | HARD CAPSULE AND METHOD FOR PRODUCING SAME | Nisshin Kasei Co., Ltd. (JP) | 2013-01-02 | — | — | EP | disclosed |
| US-20120316250-A1 | HARD CAPSULE AND METHOD FOR PRODUCING SAME | NISSHIN KASEI CO., LTD. (JP) | 2012-12-13 | — | — | US | disclosed |
| CN-101657216-B | Novel base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion | DAIDO CHEMICAL CORP | 2012-11-21 | — | — | CN | disclosed |
| CN-102369022-A | Hard capsule | NISSHIN KASEI CO LTD | 2012-03-07 | — | — | CN | disclosed |
| US-20120022169-A1 | HARD CAPSULE | NISSHIN KASEI CO., LTD. (JP) | 2012-01-26 | — | — | US | disclosed |
| CN-102292110-A | Hard capsules | — | 2011-12-21 | — | — | CN | disclosed |
| US-20110280937-A1 | HARD CAPSULE | NISSHIN KASEI CO., LTD. (JP) | 2011-11-17 | — | — | US | disclosed |
| CN-101657216-A | Novel dry solid dispersion with base, contain the solid dispersion of this base and contain the compositions of this dispersion | DAIDO CHEMICAL CORP | 2010-02-24 | — | — | CN | disclosed |
| WO-2008018825-A1 | ORAL POLYVINYL ALCOHOL CAPSULES COMPRISING PROTON PUMP INHIBITORS | ASTRAZENECA AB (SE) | 2008-02-14 | — | — | WO | disclosed |
| US-6967026-B2 | Hard capsule | Nisshin Kasel Co., Ltd. (JP) | 2005-11-22 | — | — | US | disclosed |
| US-20050186268-A1 | Hard capsule | HOSHI NOBORU (JP) | 2005-08-25 | — | — | US | disclosed |
| CN-1209091-C | Hard capsules | NISSHIN KASEI CO LTD (JP) | 2005-07-06 | — | — | CN | disclosed |
| CN-1449272-A | Hard capsule | NISSHIN KASEI CO LTD (JP) | 2003-10-15 | — | — | CN | disclosed |
| US-20030166763-A1 | Hard capsule | VENTURE LENDING & LEASING IX, INC. | 2003-09-04 | — | — | US | disclosed |